MediWound Continues Global Expansion with Distribution Agreement for NexoBrid in United Arab Emirates with Ghassan Aboud GroupGlobeNewsWire • 12/14/20
MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Will MediWound (MDWD) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 11/03/20
MediWound to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 10, 2020GlobeNewsWire • 11/02/20
MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal BurnsGlobeNewsWire • 09/16/20
MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response PreparednessGlobeNewsWire • 08/25/20
Mediwound Ltd (MDWD) CEO Sharon Malka on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
MediWound Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/06/20
MediWound to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020GlobeNewsWire • 07/28/20
MediWound Announces Submission of Biologics License Application to the U.S. FDA for NexoBrid for the Treatment of Severe Thermal BurnsGlobeNewsWire • 06/30/20
MediWound Ltd (MDWD) CEO Sharon Malka on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/20/20
MediWound Reports First Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/20/20
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/12/20
MediWound Strengthens its NexoBrid European Presence with Additional Distribution AgreementsGlobeNewsWire • 05/04/20